Tissue Engineering
Total Trials
11
As Lead Sponsor
As Collaborator
0
Total Enrollment
404
NCT02377674
Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection
Phase: N/A
Role: Lead Sponsor
Start: Oct 31, 2013
Completion: Sep 30, 2020
NCT02377700
Safety and Performance of a Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis
Start: Jun 30, 2014
NCT02700100
Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction
Start: Jun 30, 2016
Completion: Apr 30, 2022
NCT03022708
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
Start: May 8, 2017
Completion: Dec 31, 2026
NCT03405636
Xeltis Pulmonary Valved Conduit Safety and Performance Study
Start: Sep 30, 2020
Completion: Oct 31, 2026
NCT04545112
Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)
Start: Oct 22, 2020
Completion: Feb 15, 2031
NCT04898153
First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft
Start: Jun 10, 2021
Completion: Sep 30, 2027
NCT05473299
Xeltis Hemodialysis Access Graft: aXess Pivotal Study
Start: Nov 4, 2022
Completion: Dec 31, 2029
NCT06494631
Xeltis Hemodialysis Access Graft (aXess) US Study
Start: Nov 11, 2024
Completion: Jan 31, 2032
NCT06329310
Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study
Start: Dec 16, 2024
NCT06951685
Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study
Start: May 2, 2025
Completion: Sep 30, 2028
Loading map...